Generation of αGal-enhanced bifunctional tumor vaccine-Reference-Cited by-同舟云学术

Generation of αGal-enhanced bifunctional tumor vaccine

Published:2022-07 Issue:7 Volume:12 Page:3177-3186
ISSN:2211-3835
Container-title:Acta Pharmaceutica Sinica B
language:en
Short-container-title:Acta Pharmaceutica Sinica B

Author:

He Jian,Huo Yu,Zhang Zhikun,Luo Yiqun,Liu Xiuli,Chen Qiaoying,Wu Pan,Shi Wei,Wu Tao,Tang Chao,Wang Huixue,Li Lan,Liu Xiyu,Huang Yong,Zhao Yongxiang,Gan Lu,Wang Bing,Zhong Liping

Publisher

Elsevier BV

Subject

General Pharmacology, Toxicology and Pharmaceutics

Reference28 articles.

1. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012;Ferlay;Int J Cancer,2015

2. Systemic treatment of HCC in special populations;Rimassa;J Hepatol,2021

3. De novo lipogenesis is elicited dramatically in human hepatocellular carcinoma especially in hepatitis C virus-induced hepatocellular carcinoma;Li;MedComm,2020

4. Specific stimulation of T lymphocytes with erythropoietin for adoptive immunotherapy;Vinanica;Blood,2020

5. Stem-like CD8 T cells mediate response of adoptive cell immunotherapy against human cancer;Krishna;Science,2020

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Progress of Oncolytic Virus;Journal of Biomedical Nanotechnology;2024-10-01

2. Recent Advances in the Development of Membrane-derived Vesicles for Cancer Immunotherapy;Current Drug Delivery;2024-03

3. Vaccination of TLR7/8 Agonist‐Conjugated Antigen Nanoparticles for Cancer Immunotherapy;Advanced Healthcare Materials;2023-04-25

4. A metabolic intervention strategy to break evolutionary adaptability of tumor for reinforced immunotherapy;Acta Pharmaceutica Sinica B;2023-02